ReviewFrontiers in chemistry2026
FDA approved drug containing acetamide group- a mini review.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acetamide, is a fundamental structural motif widely utilized in medicinal chemistry and drug design. Its unique combination of chemical stability, hydrogen bonding acceptor and donor capacity, and ease of modification makes it a valuable functional group in the development of therapeutic agents. This review explores the role of acetamide group in enhancing drug-like properties, including solubility, membrane permeability, and metabolic stability. Acetamide moieties are frequently found in a variety of pharmacologically active compounds, such as enzyme inhibitors, anticancer agents, and anti-inflammatory drugs, where they contribute to crucial interactions at the biological target site. Additionally, the incorporation of acetamido structures into lead compounds has been shown to improve binding affinity and pharmacokinetic profiles. Recent advances in synthetic methodologies have further facilitated the incorporation of acetamido group in drug design. In this article we mainly focus on synthesis, biological activity and mechanism of action of acetamido containing FDA approved drugs. This article aims to highlight the versatility and continued relevance of acetamido as a key functional group in the discovery and optimization of modern pharmaceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.